Duerschmied, D.
Brachmann, J.
Darius, H.
Frey, N.
Katus, H. A.
Rottbauer, W.
Schäfer, A.
Thiele, H.
Bode, C.
Zeymer, Uwe
Article History
Received: 6 January 2018
Accepted: 9 April 2018
First Online: 20 April 2018
Compliance with ethical standards
:
: Duerschmied D: Speaker honoraria from Bayer, Daiichi-Sankyo, Pfizer, Brachmann J: none, Darius H: Speaker’s honoraria and consulting fees from Bayer, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Boehringer Ingelheim, Frey N: none, Katus HA: none, Rottbauer W: none, Schäfer A: Speaker honoraria from Daiichi, Bristol-Myers Squibb/Pfizer; Consulting fees from Bayer, Boehringer Ingelheim, Thiele H: none, Bode C: Research grants from Bayer, GlaxoSmithKline, Merck; Speaker’s honoraria from Bayer, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Boehringer Ingelheim; Consulting fees from Bayer, Zeymer U: Speaker’s honoraria and consulting fees from Bayer, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Boehringer Ingelheim.